The expanding family of innate lymphoid cells: Regulators and effectors of immunity and tissue remodeling

Nature Immunology

Volumn 12, Issue 1, 2011, Pages 21-27

  Spits, Hergen ^a   Di Santo, James P ^b,c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b INSTITUT PASTEUR   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INHIBITOR OF DIFFERENTIATION 2; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 22; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7; TUMOR NECROSIS FACTOR;

CYTOKINE PRODUCTION; DENDRITIC CELL; EPITHELIUM CELL; HUMAN; IMMUNE DYSREGULATION; IMMUNOPATHOLOGY; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOID CELL; LYMPHOID TISSUE; MOLECULAR EVOLUTION; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNITY, INNATE; INHIBITOR OF DIFFERENTIATION PROTEIN 2; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LYMPHOCYTES; MICE; TRANSCRIPTION FACTORS; WOUND HEALING;

EID: 78650310810     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1962     Document Type: Review

References (84)

1. Biron, C.A., Nguyen, K.B., Pien, G.C., Cousens, L.P. & Salazar-Mather, T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189-220 (1999).
2. Arase, H. & Lanier, L.L. Virus-driven evolution of natural killer cell receptors. Microbes Infect. 4, 1505-1512 (2002).
3. Trinchieri, G. Biology of natural killer cells. Adv. Immunol. 47, 187-376 (1989).
4. Di Santo, J.P. Natural killer cells: diversity in search of a niche. Nat. Immunol. 9, 473-475 (2008).
5. Lanier, L.L., Le, A.M., Civin, C.I., Loken, M.R. & Phillips, J.H. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol. 136, 4480-4486 (1986).
6. Cooper, M.A., Fehniger, T.A. & Caligiuri, M.A. The biology of human natural killer-cell subsets. Trends Immunol. 22, 633-640 (2001).
7. Fauriat, C, Long, E.O., Ljunggren, H.G. & Bryceson, Y.T. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115, 2167-2176 (2010).
8. Hayakawa, Y., Huntington, N.D., Nutt, S.L. & Smyth, M.J. Functional subsets of mouse natural killer cells. Immunol. Rev. 214, 47-55 (2006).
9. Vosshenrich, C.A. et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 7, 1217-1224 (2006).
10. Ribeiro, V.S. et al. Thymic NK Cells develop independently from T cell precursors. J. Immunol. 185, 4993-4997 (2010).
11. Huntington, N.D., Vosshenrich, C.A. & Di Santo, J.P. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat. Rev. Immunol. 7, 703-714 (2007).
12. Ashkar, A.A., Di Santo, J.P. & Croy, B.A. Interferon gamma contributes to initiation of uterine vascular modifcation, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med. 192, 259-270 (2000).
13. Gur, C. et al. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat. Immunol. 11, 121-128 (2010).
14. + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7, 493-504 (1997).
15. Mebius, R.E. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3, 292-303 (2003).
16. van de Pavert, S.A. & Mebius, R.E. New insights into the development of lymphoid tissues. Nat. Rev. Immunol. 10, 664-674 (2010).
17. Nishikawa, S.-I., Honda, K., Vieira, P. & Yoshida, H. Organogenesis of peripheral lymphoid organs. Immunol. Rev. 195, 72-80 (2003).
18. Yokota, Y. et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 702-706 (1999).
19. Sun, Z. et al. Requirement for RORy in thymocyte survival and lymphoid organ development. Science 288, 2369-2373 (2000).
20. Eberl, G. et al. An essential function for the nuclear receptor RORy(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64-73 (2004).
21. Yoshida, H. et al. Different cytokines induce surface lymphotoxin-ap on IL-7 receptor-a cells that differentially engender lymph nodes and Peyer's patches. Immunity 17, 823-833 (2002).
22. + natural killer-like cells. Nat. Immunol. 10, 66-74 (2009).
23. + lymphoid tissue inducer cells. J. Immunol. 183, 2217-2221 (2009).
24. Hamada, H. et al. Identifcation of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J. Immunol. 168, 57-64 (2002).
25. Bouskra, D. et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456, 507-510 (2008).
26. Scandella, E. et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat. Immunol. 9, 667-675 (2008).
27. Ouyang, W., Kolls, J.K. & Zheng, Y. The biological functions of T helper 17 cell effector cytokines in infammation. Immunity 28, 454-467 (2008).
28. Takatori, H. et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206, 35-41 (2009).
29. Blaho, V.A., Buczynski, M.W., Dennis, E.A. & Brown, C.R. Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17. J. Immunol. 183, 5644-5653 (2009).
30. Hsu, H.C. et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 9, 166-175 (2008).
31. Wolk, K., Witte, E., Witte, K., Warszawska, K. & Sabat, R. Biology of interleukin-22. Semin. Immunopathol. 32, 17-31 (2010).
32. Tsuji, M. et al. Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 29, 261-271 (2008).
33. Lane, P. et al. Lymphoid tissue inducer cells in adaptive CD4 T cell dependent responses. Semin. Immunol. 20, 159-163 (2008).
34. Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009).
35. + cell populations in gut and skin. Nat. Immunol. 10, 75-82 (2009).
36. + cells. Nat. Immunol. 10, 83-91 (2009).
37. + cells that provide innate mucosal immune defense. Immunity 29, 958-970 (2008).
38. + cell subsets from Id2-dependent precursors. J. Exp. Med. 207, 273-280 (2010).
39. + lineage distinct from conventional natural killer cells. J. Exp. Med. 207, 281-290 (2010).
40. + innate lymphoid cells. Science 330, 665-669 (2010).
41. Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282-289 (2008).
42. Satoh-Takayama, N. et al. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J. Immunol. 183, 6579-6587 (2009).
43. + LTi-like innate lymphoid cells by Toll like receptor 2. Immunity doi:10.1016/j.immuni.2010.10.012 (4 November 2010)
44. Cella, M., Otero, K. & Colonna, M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1β reveals intrinsic functional plasticity. Proc. Natl. Acad. Sci. USA 107, 10961-10966 (2010).
45. Buonocore, S. et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371-1375 (2010).
46. Fort, M.M. et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985-995 (2001)
47. Hurst, S.D. et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169, 443-453 (2002).
48. + lymphoid cells. Nature 463, 540-544 (2010).
49. Neill, D.R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367-1370 (2010).
50. H2 cytokine responses. Nature 464, 1362-1366 (2010).
51. Fallon, P.G. et al. Identifcation of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203, 1105-1116 (2006).
52. Owyang, A.M. et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic infammation in the gastrointestinal tract. J. Exp. Med. 203, 843-849 (2006).
53. Price, A.E. et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 107, 11489-11494 (2010).
54. Loza, M.J., Zamai, L, Azzoni, L, Rosati, E. & Perussia, B. Expression of type 1 (interferon y) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood 99, 1273-1281 (2002).
55. Veldhoen, M. et al. Transforming growth factor-p 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341-1346 (2008).
56. Mukasa, R. et al. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 32, 616-627 (2010).
57. + T cells. Science 327, 1098-1102 (2010).
58. Kee, B.L. E and ID proteins branch out. Nat. Rev. Immunol. 9, 175-184 (2009).
59. Boos, M.D., Yokota, Y., Eberl, G. & Kee, B.L. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 204, 1119-1130 (2007).
60. Heemskerk, M.H. et al. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J. Exp. Med. 186, 1597-1602 (1997).
61. Spits, H., Couwenberg, F., Bakker, A.Q., Weijer, K. & Uittenbogaart, C.H. Id2 and Id3 inhibit development of CD34+ stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J. Exp. Med. 192, 1775-1784 (2000).
62. Gascoyne, D.M. et al. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 10, 1118-1124 (2009).
63. Kamizono, S. et al. Nfl3/E4bp4 is required for the development and maturation of NK cells in vivo. J. Exp. Med. 206, 2977-2986 (2009).
64. Ivanov, I.I. et al. The orphan nuclear receptor RORyt directs the differentiation program of proinfammatory IL-17+ T helper cells. Cell 126, 1121-1133 (2006).
65. H17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106-109 (2008).
66. H2 cells. Nat. Immunol. 10, 864-871 (2009).
67. Wincent, E. et al. The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2-b]carbazole is present in humans. J. Biol. Chem. 284, 2690-2696 (2009).
68. Wilkinson, B. et al. TOX: an HMG box protein implicated in the regulation of thymocyte selection. Nat. Immunol. 3, 272-280 (2002).
69. Aliahmad, P., de la Torre, B. & Kaye, J. Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nat. Immunol. 11, 945-952 (2010).
70. + T cell homeostasis. J. Exp. Med. 200, 825-834 (2004).
71. Koka, R. et al. Interleukin (IL)-15Ra-defcient natural killer cells survive in normal but not IL-15Ra-defcient mice. J. Exp. Med. 197, 977-984 (2003).
72. Mortier, E., Woo, T., Advincula, R., Gozalo, S. & Ma, A. IL-15Ra chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J. Exp. Med. 205, 1213-1225 (2008).
73. + severe combined immunodefciency. Nat. Genet. 20, 394-397 (1998).
74. Huntington, N.D. et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 206, 25-34 (2009).
75. bright natural killer cells. Immunity 22, 295-304 (2005).
76. Freud, A.G. et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J. Exp. Med. 203, 1033-1043 (2006).
77. H17 cytokine interleukin-22. Blood 113, 4008-4010 (2009).
78. + immature human natural killer cells in secondary lymphoid tissue. Immunity 32, 803-814 (2010).
79. Ahern, P.P. et al. Interleukin-23 drives intestinal infammation through direct activity on T cells. Immunity 33, 279-288 (2010).
80. Uhlig, H.H. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309-318 (2006).
81. Duerr, R.H. et al. A genome-wide association study identifes IL23R as an infammatory bowel disease gene. Science 314, 1461-1463 (2006).
82. Eisenring, M., Vom Berg, J., Kristiansen, G., Saller, E. & Becher, B. IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46. Nat. Immunol. 11, 1030-1038 (2010).
83. Lane, P.J.L., Gaspal, F.M.C. & Kim, M.-Y. Two sides of a cellular coin: CD4+CD3-cells regulate memory responses and lymph-node organization. Nat. Rev. Immunol. 5, 655-660 (2005).
84. Khalturin, K., Panzer, Z., Cooper, M.D. & Bosch, T.C. Recognition strategies in the innate immune system of ancestral chordates. Mol. Immunol. 41, 1077-1087 (2004).